Also listed on Transave, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 5, 2026 · Medium confidence
20-year base term ends Dec 5, 2026
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,402,845), so the cap could be lower.
Dec 5, 2006
Dec 5, 2026
Jan 24, 2017
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 5, 2006, when application 11/634,343, the earliest non-provisional in its chain, was filed (this one was filed Jul 8, 2016) | Dec 5, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,402,845, US 9,511,082, US 9,549,925) | resolves to Dec 5, 2026, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 5, 2026 | Medium confidence |
This family
| US 8,226,975 | In force Aug 2028 | Aug 2028 |
| US 8,632,804 | In force Dec 2026 | Dec 2026 |
| US 8,679,532 | In force Dec 2026 | Dec 2026 |
| US 8,642,075 | In force Dec 2026 | Dec 2026 |
| US 8,673,348 | In force Dec 2026 | Dec 2026 |
| US 8,673,349 | In force Dec 2026 | Dec 2026 |
| Application 14/080,922 | Abandoned not computed | not computed |
| US 9,402,845 | In force no later than Dec 2026 | no later than Dec 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 21, 2016 Reel 39214, frame 173 | Weers, Jeff | Transave, Inc. | Assignment of Assignor's Interest |
| Jul 21, 2016 Reel 39214, frame 185 | Transave, Inc. | Transave, LLC | Merger |
| Jul 21, 2016 Reel 39214, frame 201 | Transave, LLC | Insmed Incorporated | Assignment of Assignor's Interest |
| Oct 19, 2022 Reel 61727, frame 39 | Insmed Incorporated | Orbimed Royalty & Credit Opportunities IV, LP | Second Lien Patent Security Agreement |
| Oct 20, 2022 Reel 61735, frame 875 | Insmed Incorporated | Biopharma Credit PLC | Patent Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 9,402,845, US 9,511,082, US 9,549,925, ends no earlier than this term, so it caps nothing.